Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-Qol) to treatment for acne vulgaris in placebo-controlled clinical trials

Quality of Life Research

Volumn 11, Issue 8, 2002, Pages 809-816

  Fehnel, Sheri E ^a   McLeod, L D ^a   Brandman, J ^b   Arbit, D I ^b   McLaughlin Miley, C J ^c   Coombs, J H ^d   Martin, A R ^e   Girman, C J ^e  

^a RTI HEALTH SOLUTIONS   (United States)

^b Pfizer Pharmaceutical Group   (United States)

^c PFIZER INC   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Acne vulgaris; Facial dermatoses; Psychometrics; Quality of life; Skin diseases

Indexed keywords

ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; PLACEBO;

ACNE SPECIFIC QUALITY OF LIFE QUESTIONNAIRE; ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FACTORIAL ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; TREATMENT OUTCOME;

ACNE VULGARIS; ADOLESCENT; ADULT; CONTROLLED CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PATIENT PARTICIPATION; PLACEBOS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; UNITED STATES;

EID: 0036892556     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020880005846     Document Type: Article

References (16)

1. Bergfeld WF. The evaluation and management of acne: Economic considerations. J Am Acad Dermatol 1995; 32: S52-S56.
2. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987; 17: 25-32.
3. Gupta MA, Gupta AK, Schork NJ, Ellis CN, Voorhees JJ. Psychiatric aspects of the treatment of mild to moderate facial acne. Int J Dermatol 1990; 29: 719-721.
4. Koo J. The psychosocial impact of acne: Patient's perceptions. J Am Acad Dermatol 1995; 32: S26-S30.
5. Lydick E, Yawn, BP. Clinical interpretation of health-related quality of life data. In: Staquet MJ, Hays RD, Fayers PM (eds), Quality of Life Assessment in Clinical Trials. New York: Oxford University Press, 1998, 299-314.
6. Girman CJ, Hartmaier S, Thiboutout D, et al. Evaluating health-related quality of life in patients with facial acne: Development of a self-administered questionnaire for clinical trials. Qual Life Res 1996; 5: 481-490.
7. Merck and Co., Inc. Acne-Specific Quality of Life Questionnaire (Acne-QoL): Manual and Interpretation Guide. Whitehouse Station, NJ: Merck and Co., Inc., 1997.
8. Martin AR, Lookingbill DP, Botek A, Light J, Thiboutout D, Girman CJ. Health related quality of life among patients with facial acne: Assessment of a new acne-specific questionnaire. Clin Exp Dermatol 2001; 26: 380-385.
9. Maloney JM, Arbit DI, Flack M, McLaughlin-Miley CJ, Sevilla C, Derman R. Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol (Estrostep®) in the treatment of moderate acne vulgaris. Clin J Women's Health 2001; 1: 123-131.
10. Guyatt GH, Walter SD, Norman G. Measuring change over time: Assessing the usefulness of evaluative instruments. J Chronic Dis 1987; 40: 171-178.
11. Jöreskog KG, Sörbom D. LISREL® 8: User's Reference Guide. Chicago, Illinois: Scientific Software International, Inc., 1996.
12. Schumacker RE, Lomax RG. A Beginner's Guide to Structural Equation Modeling. Mahwah, NJ: Erlbaum, 1996.
13. Samejima F. Estimation of latent ability using a response pattern of graded scores. Psychometric Monograph, 1969, no. 17.
14. Thissen D. MULTILOG™ User's Guide: Version 6.0. Chicago, Illinois: Scientific Software International, Inc., 1991.
15. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1977; 8.
16. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. 2nd Ed. New York: Oxford University Press, 1995; 65.